Skip to main content
Clinical Trials/ACTRN12621000679886
ACTRN12621000679886
Completed
未知

Intensive long-term rehabilitation for people livingwith chronic spinal cord injury: a feasibility trial

Griffith University0 sites5 target enrollmentJune 3, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Spinal Cord Injury
Sponsor
Griffith University
Enrollment
5
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 3, 2021
End Date
June 17, 2022
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion/exclusion criteria for participants have been determined in consultation with medical and
  • rehabilitation specialists including a clinician with a lived experience of SCI.
  • Participants are eligible to be included in the study only if all the following criteria apply:
  • i. Have sustained a traumatic spinal cord injury a minimum of 12 months prior to consent
  • and have completed their primary rehabilitation;
  • ii. Have stable neurological level and functional ability of more than 6 months in duration;
  • iii. Are over 18 years and able to give informed consent;
  • iv. Are ASIA A or B (as per the International Standards for Neurological Classification of
  • v. Are able and willing to attend an exercise program five times per week for 26 (16 weeks 'on\-site' and 10 weeks 'at\-home') weeks;
  • vi. Are considered by their general practitioner or specialist medical consultant to be fit to

Exclusion Criteria

  • Participants are excluded from the study if any of the following criteria apply:
  • i. Have significant concomitant central nervous system, peripheral nervous system or
  • musculoskeletal system injuries or disorders limiting ability to exercise;
  • ii. Have had recent major trauma or surgery within the last 6 months;
  • iii. Have an existing stage 3 or 4 pressure ulcer according to the National Pressure Ulcer
  • Advisory Panel classification;
  • iv. Have endocrinopathy or metabolic disorders of the bone, such as Paget’s disease, lytic
  • or renal bone disease, and senile osteoporosis;
  • v. Have a medical history of exposure to medication(s) known to affect mineral or bone
  • metabolism;

Outcomes

Primary Outcomes

Not specified

Similar Trials